BRCA1 and BRCA2 pathogenic variants and prostate cancer risk: systematic review and meta-analysis
Published 2021 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
BRCA1 and BRCA2 pathogenic variants and prostate cancer risk: systematic review and meta-analysis
Authors
Keywords
-
Journal
BRITISH JOURNAL OF CANCER
Volume -, Issue -, Pages -
Publisher
Springer Science and Business Media LLC
Online
2021-12-29
DOI
10.1038/s41416-021-01675-5
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Rare Germline Pathogenic Variants Identified by Multigene Panel Testing and the Risk of Aggressive Prostate Cancer
- (2021) Tú Nguyen-Dumont et al. Cancers
- Prostate Cancer Risk by BRCA2 Genomic Regions
- (2020) Tommy Nyberg et al. EUROPEAN UROLOGY
- Mutations in ATM , NBN and BRCA2 predispose to aggressive prostate cancer in Poland
- (2020) Dominika Wokołorczyk et al. INTERNATIONAL JOURNAL OF CANCER
- The association of BRCA1 and BRCA2 mutations with prostate cancer risk, frequency, and mortality: A meta‐analysis
- (2019) Mok Oh et al. PROSTATE
- Germline pathogenic variants in 7,636 Japanese patients with prostate cancer and 12,366 controls
- (2019) Yukihide Momozawa et al. JNCI-Journal of the National Cancer Institute
- Prostate Cancer Risks for Male BRCA1 and BRCA2 Mutation Carriers: A Prospective Cohort Study
- (2019) Tommy Nyberg et al. EUROPEAN UROLOGY
- Interim Results from the IMPACT Study: Evidence for Prostate-specific Antigen Screening in BRCA2 Mutation Carriers
- (2019) Elizabeth C. Page et al. EUROPEAN UROLOGY
- Inherited DNA-Repair Gene Mutations in Men with Metastatic Prostate Cancer
- (2016) Colin C. Pritchard et al. NEW ENGLAND JOURNAL OF MEDICINE
- Increased risk of male cancer and identification of a potential prostate cancer cluster region inBRCA2
- (2015) Henriette Roed Nielsen et al. ACTA ONCOLOGICA
- Cancer risks in Jewish male BRCA1 and BRCA2 mutation carriers
- (2015) Yael Laitman et al. BREAST CANCER RESEARCH AND TREATMENT
- Gene-Panel Sequencing and the Prediction of Breast-Cancer Risk
- (2015) Douglas F. Easton et al. NEW ENGLAND JOURNAL OF MEDICINE
- Conducting Meta-Analyses inRwith themetaforPackage
- (2015) Wolfgang Viechtbauer Journal of Statistical Software
- The impact of a BRCA2 mutation on mortality from screen-detected prostate cancer
- (2014) M R Akbari et al. BRITISH JOURNAL OF CANCER
- GermlineBRCAMutations Are Associated With Higher Risk of Nodal Involvement, Distant Metastasis, and Poor Survival Outcomes in Prostate Cancer
- (2013) Elena Castro et al. JOURNAL OF CLINICAL ONCOLOGY
- An inherited NBN mutation is associated with poor prognosis prostate cancer
- (2012) C Cybulski et al. BRITISH JOURNAL OF CANCER
- Germline BRCA1 mutations increase prostate cancer risk
- (2012) D Leongamornlert et al. BRITISH JOURNAL OF CANCER
- BRCA2 is a moderate penetrance gene contributing to young-onset prostate cancer: implications for genetic testing in prostate cancer patients
- (2011) Z Kote-Jarai et al. BRITISH JOURNAL OF CANCER
- Risk of cancer other than breast or ovarian in individuals with BRCA1 and BRCA2 mutations
- (2011) A. Moran et al. Familial Cancer
- BRCA1 mutations do not increase prostate cancer risk: Results from a meta-analysis including new data
- (2011) Laura Fachal et al. PROSTATE
- Germline BRCA Mutations Denote a Clinicopathologic Subset of Prostate Cancer
- (2010) D. J. Gallagher et al. CLINICAL CANCER RESEARCH
- Associations of High-Grade Prostate Cancer with BRCA1 and BRCA2 Founder Mutations
- (2009) I. Agalliu et al. CLINICAL CANCER RESEARCH
- The Risk of Prostate Cancer amongst Black Men in the United Kingdom: The PROCESS Cohort Study
- (2007) Yoav Ben-Shlomo et al. EUROPEAN UROLOGY
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now